Tech Mahindra and ArisGlobal Partner to Provide the Life Sciences Industry with an End-to-End Solution for IDMP Compliance

Jun 20, 2016

ArisGlobal®, a leading provider of cloud-based software solutions for life sciences and Tech Mahindra Limited, a leading provider of IT, Networks & Engineering solutions and BPO services have partnered to provide the life sciences industry with a complete end-to-end solution that addresses IDMP regulatory compliance requirements and provides a solution which will improve efficiencies and assure the safety of their products.

The solution provides both the technology as well as experience needed to provide companies with a clear path towards compliance and beyond. The IDMP solution helps companies to assess, collect and verify the information needed to achieve compliance through an integrated application.

Atul Kunwar, Chief Technology Officer – Tech Mahindra, commented that “This engagement marks the coming together of two pioneering organisations.” Venugopal Kandimalla, Global Head – Healthcare Life-Sciences Vertical at Tech Mahindra added that “Our alliance with ArisGlobal fosters mutual growth in regulatory space.” Dr Palakodeti Ratnakar, Vice President, Life Sciences Practice – Tech Mahindra, has concluded that “This joint solution comprising of Master Data Management and regulatory interfacing application caters to EMA-IDMP compliance requirements of pharmaceutical companies.”

Wim Cypers, Senior Vice President – ArisGlobal, stated “It’s clear that IDMP will impact other regulatory areas, not in the least the area of patient safety and benefit/risk management. This partnership not only unites the regulatory and MDM expertise of both companies but also leverages our vast experience in other domains that will be impacted by IDMP.”

About ArisGlobal

ArisGlobal’s (https://live-arisglobal.pantheonsite.io) innovative cloud-based solutions facilitate global drug development and regulatory compliance within the Life Sciences and Healthcare industries. Its cloud platform supports the entire product life cycle including Clinical Development, Regulatory Affairs, Pharmacovigilance and Medical Communications. Over 200 drug and device manufacturers, CROs and regulatory agencies leverage ArisGlobal®’s advanced technology solutions to make better and more informed decisions, facilitate compliance, reduce risk and improve operational efficiency. Headquartered in the United States, ArisGlobal® has regional offices in Europe, India and Japan.

LATEST NEWS

About ArisGlobal

ArisGlobal is transforming the way today’s most successful Life Sciences companies develop breakthroughs and bring new products to market. Our end-to-end drug development technology platform, LifeSphere®, integrates our proprietary Nava® cognitive computing engine to automate all core functions of the drug development lifecycle. Designed with deep expertise and a long-term perspective that spans more than 30 years, LifeSphere® is a unified platform that boosts efficiency, ensures compliance, delivers actionable insights, and lowers total cost of ownership through multi-tenant SaaS architecture.

Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China. For more updates, follow ArisGlobal on LinkedIn and Twitter.

Additional Information

Connect with ArisGlobal on LinkedIn: linkedin.com/company/aris-global
Follow @Aris_Global on Twitter: twitter.com/aris_global

Contact

Erika Thomas
ArisGlobal
+305-726-6601 | ethomas@arisglobal.com